Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Commercial
In one of biotech’s hottest areas and with big partners like…
Commercial
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution…
Commercial
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief…
Commercial
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
In one of biotech’s hottest areas and with big partners like…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 –…
Commercial
The European Commission has Granted Orphan Medicinal Product Designation in the…
Commercial
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study…
Commercial
Discovery of new step in how brain cells work could lead…
Home
Commercial
Commercial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Commercial
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 – FirstWord Pharma
Firstwordpharma News
-
July 4, 2020
Commercial
The European Commission has Granted Orphan Medicinal Product Designation in the EU for MIV-818 – FirstWord Pharma
Commercial
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study – FirstWord Pharma
Commercial
Discovery of new step in how brain cells work could lead to new therapies for epilepsy – FirstWord Pharma
Commercial
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Commercial
In one of biotech’s hottest areas and with big partners like...
Firstwordpharma News
-
July 4, 2020
0
Commercial
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution...
Firstwordpharma News
-
July 4, 2020
0
Commercial
The European Commission has Granted Orphan Medicinal Product Designation in the...
Biospace News
-
July 3, 2020
0
Clinical
EFPIA response to the consultation on the Pharmaceutical Strategy Roadmap –...
Firstwordpharma News
-
July 3, 2020
0
Commercial
Novartis resolves legacy litigation matters, finalizing settlement of speaker program litigation...
Globenewswire News
-
July 2, 2020
0
1
2
3
...
559
Page 1 of 559
- Advertisement -
MOST POPULAR
Pharming Reports On Annual General Meeting Of Shareholders
May 22, 2019
Alpine Immune Sciences Presents Preclinical ALPN-101 GvHD Data at the 2019...
February 19, 2019
Study: Regeneron’s garetosmab reduces bone lesions in patients with fibrodysplasia ossificans...
January 9, 2020
PRA Health Sciences Melancarkan Program Pemantauan COVID-19 Nasdaq:PRAH
March 23, 2020
Load more
HOT NEWS
Phase III
Allergan and Molecular Partners Announce Topline Safety Results from MAPLE study...
Commercial
Bolt Biotherapeutics Pushes Forward with Initiatives Following $93.5 Million Series C
Commercial
HUYA Bioscience International Appoints Meiji Seika Pharma as Exclusive Distributor For...
Deals
Open Orphan: New hVIVO contract signed with a European Biotech Company
